[HTML][HTML] Biomimetic nanomedicines for precise atherosclerosis theranostics
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD),
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
Biomimetic nanomedicines for precise atherosclerosis theranostics
Y Tao, X Lan, Y Zhang, C Fu, L Liu… - Acta pharmaceutica …, 2023 - pubmed.ncbi.nlm.nih.gov
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD),
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
Biomimetic nanomedicines for precise atherosclerosis theranostics.
Y Tao, X Lan, Y Zhang, C Fu, L Liu, F Cao… - Acta Pharmaceutica …, 2022 - europepmc.org
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD),
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
[HTML][HTML] Biomimetic nanomedicines for precise atherosclerosis theranostics
Y Tao, X Lan, Y Zhang, C Fu, L Liu… - Acta Pharmaceutica …, 2023 - ncbi.nlm.nih.gov
Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD),
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …
creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment …